A031860 Stock Overview
A medical company, develops and sells brain disease treatment devices based on image guided low intensity focused ultrasound technology in the brain neuromodulation market.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
SU-Holdings Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩1,272.00 |
52 Week High | ₩9,510.00 |
52 Week Low | ₩971.00 |
Beta | 0.51 |
11 Month Change | 8.53% |
3 Month Change | -12.76% |
1 Year Change | -84.04% |
33 Year Change | -89.17% |
5 Year Change | -90.25% |
Change since IPO | -99.95% |
Recent News & Updates
Shareholder Returns
A031860 | KR Leisure | KR Market | |
---|---|---|---|
7D | -3.9% | 2.3% | 3.8% |
1Y | -84.0% | -36.6% | 5.8% |
Return vs Industry: A031860 underperformed the KR Leisure industry which returned -36.6% over the past year.
Return vs Market: A031860 underperformed the KR Market which returned 5.8% over the past year.
Price Volatility
A031860 volatility | |
---|---|
A031860 Average Weekly Movement | 11.7% |
Leisure Industry Average Movement | 5.9% |
Market Average Movement | 6.7% |
10% most volatile stocks in KR Market | 12.1% |
10% least volatile stocks in KR Market | 3.5% |
Stable Share Price: A031860's share price has been volatile over the past 3 months.
Volatility Over Time: A031860's weekly volatility has decreased from 18% to 12% over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1979 | 18 | Moon-Wui Chung | su-holdings.com |
SU-Holdings Co.,Ltd., a medical company, develops and sells brain disease treatment devices based on image guided low intensity focused ultrasound technology in the brain neuromodulation market. Its product is NEUROSONA, a treatment device for brain disease. The company was formerly known as NSN Co., Ltd.
SU-Holdings Co.,Ltd. Fundamentals Summary
A031860 fundamental statistics | |
---|---|
Market cap | ₩19.11b |
Earnings (TTM) | -₩19.44b |
Revenue (TTM) | ₩12.29b |
1.6x
P/S Ratio-1.0x
P/E RatioIs A031860 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A031860 income statement (TTM) | |
---|---|
Revenue | ₩12.29b |
Cost of Revenue | ₩11.43b |
Gross Profit | ₩861.59m |
Other Expenses | ₩20.30b |
Earnings | -₩19.44b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.29k |
Gross Margin | 7.01% |
Net Profit Margin | -158.21% |
Debt/Equity Ratio | 2.6% |
How did A031860 perform over the long term?
See historical performance and comparison